$HNOI

HNO International, Inc.

CIK:0001342916|SEC Filings

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 33,821	$ 43,708
Cost of goods sold	0	0	0	0
Gross Profit	0	0	33,821	43,708
Operating expenses
Advertising and marketing	0	2,610	2,559	22,770
General and administrative expenses	186,014	180,560	472,583	796,989
Share commitment expenses	0	241,380	55,000	5,333,937
Depreciation	63,716	66,742	192,369	178,730
Total Operating Expenses	249,730	491,292	722,511	6,332,426
Net loss from Operations	(249,730)	(491,292)	(688,690)	(6,288,718)
Other Income (Expenses)
Interest income	11	2	17	8
Interest expense	(94,086)	(6,705)	(140,651)	(20,569)
Gain/(Loss) on fair value of convertible note	(143,229)	(15)	(231,390)	(15,000)
Gain/(Loss) on derivative	(45,175)	0	(98,878)	0
Loss on write-off of intangible asset	0	0	0	(105,190)
Total Other (Expenses)	(282,479)	(6,718)	(470,902)	(140,751)
Net Loss	$ (532,209)	$ (498,010)	$ (1,159,592)	$ (6,429,469)
PER SHARE AMOUNTS
Basic net loss per share	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.04)
Diluted net loss per share	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.04)
Weighted average number of common shares outstanding - basic	102,198,076	85,983,969	101,792,638	171,019,802
Weighted average number of common shares outstanding - diluted	102,198,076	85,983,969	101,792,638	171,019,802

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Cash Flow from Operating Activities
Net loss	$ (1,159,592)	$ (6,429,469)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	192,369	178,730
Non cash interest expenses	111,685	0
Legal services provided in exchange for convertible note	0	45,000
Loss on write-off of intangible asset	0	105,190
(Gain)/Loss on fair value of convertible note	231,390	15,000
(Gain)/Loss on derivative liability	98,878	0
Share based compensation	0	5,333,937
Commitment shares issued for financing expense	55,000	0
Changes in operating assets and liabilities:
(Increase)/Decrease in accounts receivable	332,669	0
(Increase)/Decrease in other receivable	1,000	0
(Decrease) in accounts payable	(320,180)	(129,137)
Increase/(Decrease) in accrued payroll	0	(17,762)
Increase in accrued interest payable	20,568	20,569
Operating lease ROU assets and lease liabilities, net	(1,013)	115
Net Cash Used in Operating Activities	(437,226)	(877,827)
Cash Flows from Financing Activities
Proceeds from related party advances	230,045	509,000
Repayment of related party advances	(45,000)	(378,000)
Proceeds from sale of common stock	67,500	936,500
Proceeds from issuance of convertible notes payable	407,750	0
Repayment of convertible notes payable	(150,000)	0
Net Cash Provided by Financing Activities	510,295	1,067,500
Cash Flows from Investing Activities
Purchase of property and equipment	(13,167)	(177,944)
Net Cash Used in Investing Activities	(13,167)	(177,944)
Net increase (decrease) in cash	59,902	11,729
Cash at beginning of period	9,525	20,255
Cash at end of period	69,427	31,984
Supplemental Disclosure for Cash Paid:
Lease liability paid during the period	46,695	0
Income taxes paid during the period	0	0
Interest paid during the period	897	0
Supplemental Disclosure for Non-Cash Investing and Financing Activities:
Property and equipment acquired through accounts payable	0	398,845
Common stock issued in settlement of common stock payable	60,000	0
Common stock cancellation per share exchange agreement	0	(360,000)
Series B preferred stock issuance per exchange agreement	0	360,000
Shares issued upon conversion of convertible notes payable	47,446	0
Convertible note issued in exchange for legal services, recorded at fair value	0	60,000
Derivative liability balance	$ 450,164	$ 0

CONDENSED BALANCE SHEETS - USD ($)	Jul. 31, 2026	Oct. 31, 2025
Current Assets
Cash	$ 69,427	$ 9,525
Accounts receivable	0	332,669
Other receivable	18	1,018
Total Current Assets	69,445	343,212
Non-Current Assets
Property and equipment, net	1,143,987	1,323,189
Right-of-use asset	20,197	64,637
Total Non-Current Assets	1,164,184	1,387,826
TOTAL ASSETS	1,233,629	1,731,038
Current Liabilities
Accounts payable	395,056	715,236
Accrued interest payable	76,913	56,345
Lease liability	20,702	60,953
Advances, related party	1,273,430	1,088,385
Convertible notes payable, net of discounts and issue costs	99,685	59,867
Notes payable, related party	785,000	785,000
Derivative liability	450,164	0
Total Current Liabilities	3,100,950	2,765,786
Non-Current Liability
Lease liability	0	5,202
Long term notes payable, related party	590,000	590,000
Total Non-Current Liability	590,000	595,202
Total Liabilities	3,690,950	3,360,988
STOCKHOLDERS’ DEFICIT
Common stock, par value $0.001 per share; 985,000,000 shares authorized; 102,355,323 and 100,795,491 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively	102,356	100,795
Common stock payable	25,250	25,250
Common stock subscription receivable	(13,750)	(13,750)
Additional paid-in capital	50,633,245	50,302,585
Accumulated deficit	(53,209,782)	(52,050,190)
Total Stockholders’ Deficit	(2,457,321)	(1,629,950)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	1,233,629	1,731,038
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred stock, value	5,000	5,000
Series B Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred stock, value	$ 360	$ 360